Content about Frank DellaFera

February 3, 2011
Puralube re-enters market

Fera Pharmaceuticals on Wednesday announced the reintroduction of the nonprescription dry-eye remedy Puralube ophthalmic ointment due to demand for the product.

NEW YORK — Fera Pharmaceuticals on Wednesday announced the reintroduction of the nonprescription dry-eye remedy Puralube ophthalmic ointment due to demand for the product.

“Puralube is a product that fits perfectly with our eye care portfolio,” stated Frank DellaFera, president of Fera. “We are so pleased to make Puralube available again, giving patients, pharmacists and physicians a cost-effective and reliable treatment option for dry-eye symptoms.”

December 7, 2010
Reporters Notebook, Chain Pharmacy 12/13/10

Supplier News — Fera Pharmaceuticals has recently launched two new topical ointments. The New York-based company has developed Ilotycin (erythromycin) and Garamycin (gentamicin) ophthalmic ointments, both for the treatment of bacterial infections of the eye. “Our goal is simple: to keep more quality healthcare choices alive for the people who need them,” company co-founder Frank DellaFera said.